{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:21:33Z","timestamp":1777666893595,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA207287"],"award-info":[{"award-number":["CA207287"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"WesternU intramural startup","award":["1395"],"award-info":[{"award-number":["1395"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neuint.2019.104603","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:31:00Z","timestamp":1573817460000},"page":"104603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva)"],"prefix":"10.1016","volume":"132","author":[{"given":"W.","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.A.","family":"Darmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2019.104603_bib1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s10637-018-0591-z","article-title":"A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors","volume":"36","author":"Aghajanian","year":"2018","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.neuint.2019.104603_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2013.08.047","article-title":"The role of vagal neurocircuits in the regulation of nausea and vomiting","volume":"722","author":"Babic","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib3","series-title":"Goodman and Gilman's: the Pharmacologic Basis of Therapeutics","first-page":"461","article-title":"Pharmacotherapy of psychosis and mania","author":"Baldessarini","year":"2006"},{"key":"10.1016\/j.neuint.2019.104603_bib4","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2019.104603_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2019.104603_bib6","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2019.104603_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fnins.2015.00413","article-title":"Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology","volume":"9","author":"Browning","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2019.104603_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neuint.2019.104603_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pbb.2011.05.025","article-title":"Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva)","volume":"99","author":"Darmani","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2019.104603_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2017.05.014","article-title":"The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva)","volume":"809","author":"Darmani","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2008.10.063","article-title":"A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew","volume":"1248","author":"Darmani","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104603_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2012.09.008","article-title":"Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1\/2- and PKA- phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotisparva) brainstem","volume":"698","author":"Darmani","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib13","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1021\/cr900117p","article-title":"Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting","volume":"109","author":"Darmani","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neuint.2019.104603_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2008.03.077","article-title":"Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists","volume":"1214","author":"Darmani","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104603_bib15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s007020050222","article-title":"The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)","volume":"106","author":"Darmani","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuint.2019.104603_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pbb.2015.02.010","article-title":"Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1\/2, PKA and PKC activation","volume":"131","author":"Darmani","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2019.104603_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2013.08.052","article-title":"Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva)","volume":"722","author":"Darmani","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.012","article-title":"Preface. New vistas in the pharmacology and neurochemistry of diverse causes of nausea and vomiting","volume":"722","author":"Darmani","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s007020050118","article-title":"Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis","volume":"105","author":"Darmani","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuint.2019.104603_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S1461145704004535","article-title":"AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test","volume":"7","author":"Gould","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","article-title":"A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin","volume":"33","author":"Gray","year":"2015","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.neuint.2019.104603_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.taap.2015.08.007","article-title":"Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK\/GSK-3\u03b2 pathway independent of PI3K\/Akt","volume":"288","author":"He","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0959-8049(02)00674-3","article-title":"Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists","volume":"39","author":"Hesketh","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuint.2019.104603_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156877","article-title":"Phosphorylations of serines 21\/9 in glycogen synthase kinase 3\u03b1\/\u03b2 are not required for cell lineage commitment or WNT signaling in the normal mouse intestine","volume":"11","author":"Hey","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2019.104603_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(88)91131-6","article-title":"Distribution of muscarinic cholinergic receptors in the dorsal vagal complex and other selected nuclei in the human medulla","volume":"447","author":"Hyde","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2019.104603_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.pbb.2006.11.018","article-title":"The effects of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus","volume":"85","author":"Javaid","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2019.104603_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnmol.2018.00297","article-title":"Molecular mechanisms of lithium action: switiching the light on multiple targets for dementia using animal models","volume":"11","author":"Kerr","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2019.104603_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2016.09.058","article-title":"Natural and synthetic bioactive inhibitors of glycogen synthase kinase","volume":"125","author":"Khan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2019.104603_bib29","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00032.2004","article-title":"Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity","volume":"288","author":"Kuemmerle","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuint.2019.104603_bib30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1159\/000373953","article-title":"Genistein stimulates jejunum chloride secretion via an Akt-mediated pathway in intact female mice","volume":"35","author":"Leung","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuint.2019.104603_bib31","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.bbadis.2018.07.034","article-title":"Pigment epithelium derived factor regulates human Sost\/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk\/GSK-3beta\/beta-catenin signaling","volume":"1864","author":"Li","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.neuint.2019.104603_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0091-3057(89)90399-7","article-title":"8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin, or xylazine","volume":"33","author":"Lucott","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2019.104603_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","article-title":"Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy","volume":"273","author":"Luo","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuint.2019.104603_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2010.06.007","article-title":"The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice","volume":"12","author":"Martins","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.neuint.2019.104603_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/diseases7010022","article-title":"Roles of PI3K\/AKT\/GSK3 pathway involved in psychiatric illnesses","volume":"7","author":"Matsuda","year":"2019","journal-title":"Diseases"},{"key":"10.1016\/j.neuint.2019.104603_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neuroscience.2012.09.020","article-title":"Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action","volume":"226","author":"Mazzardo-Martins","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2019.104603_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2006.07.050","article-title":"Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3beta phosphorylation and coupling with 14-3-3","volume":"143","author":"Mwangi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2019.104603_bib38","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.2147\/OTT.S158570","article-title":"Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting","volume":"11","author":"Navari","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.neuint.2019.104603_bib39","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo","volume":"102","author":"Noble","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2019.104603_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1254\/jjp.64.109","article-title":"Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus","volume":"64","author":"Okada","year":"1994","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/thno.14334","article-title":"Glycogen synthase kinase-3 (GSK-3)-Targeted therapy and imaging","volume":"6","author":"Pandey","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.neuint.2019.104603_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.heares.2009.08.001","article-title":"Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells","volume":"257","author":"Park","year":"2009","journal-title":"Hear. Res."},{"key":"10.1016\/j.neuint.2019.104603_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/rej.2017.1956","article-title":"Polygonatum sibiricum polysaccharide promotes osteoblastic differentiation through the ERK\/GSK-3\u03b2\/\u03b2-Catenin signaling pathway in vitro","volume":"21","author":"Peng","year":"2018","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.neuint.2019.104603_bib44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cellsig.2011.09.009","article-title":"Functional significance of glycogen synthase kinase-3 regulation by serotonin","volume":"24","author":"Polter","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuint.2019.104603_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-018-0722-6","article-title":"The CXCL5\/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK\/GSK-3\u03b2\/snail signalling","volume":"37","author":"Qiu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neuint.2019.104603_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2009.08.010","article-title":"Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervoussystem of the least shrew (Cryptotis parva)","volume":"94","author":"Ray","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"18","key":"10.1016\/j.neuint.2019.104603_bib47","article-title":"Akt in cancer: mediator and more","author":"Revathidevi","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neuint.2019.104603_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2016.06.001","article-title":"Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats","volume":"786","author":"Rock","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2013.06.075","article-title":"PKB\/SGK-dependent GSK3-phosphorylation in the regulation of LPS-induced Ca2+ increase in mouse dendritic cells","volume":"437","author":"Russo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2019.104603_bib50","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/15384047.2019.1595283","article-title":"Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses","volume":"20","author":"Sahin","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.neuint.2019.104603_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056258","article-title":"Jejunal proteins secreted by db\/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance","volume":"8","author":"Salinari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2019.104603_bib52","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejmech.2017.11.103","article-title":"Glycogen synthase kinase-3 and its inhibitors: potential target for various therapeutic conditions","volume":"144","author":"Saraswati","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2019.104603_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088637","article-title":"Decreased store operated Ca2+ entry in dendritic cells isolated from mice expressing PKB\/SGK-resistant GSK3","volume":"9","author":"Schmid","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2019.104603_bib54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.physbeh.2013.08.015","article-title":"2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus","volume":"120","author":"Sticht","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuint.2019.104603_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"TAUROS Investigators. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2019.104603_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neucir.2011.12.006","article-title":"AR-A014418 as a glycogen synthase kinase-3 inhibitor: anti-apoptotic and therapeutic potential in experimental spinal cord injury","volume":"24","author":"Tun\u00e7demir","year":"2013","journal-title":"Neurocirugia"},{"key":"10.1016\/j.neuint.2019.104603_bib57","first-page":"R950","article-title":"Behaviors of hypoglossal hyoid motoneurons in laryngeal and vestibular reflexes and in deglutition and emesis","volume":"274","author":"Umezaki","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuint.2019.104603_bib58","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: revisiting glycogen synthase kinase-3\u03b2 as a target for the treatment of cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuint.2019.104603_bib59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bmcl.2010.11.026","article-title":"The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3)","volume":"21","author":"Wang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuint.2019.104603_bib60","first-page":"236","article-title":"An assay of drug-induced emesis in the squirrel monkey (Saimiri sciureus)","volume":"48","author":"Wooldridge","year":"2019"},{"key":"10.1016\/j.neuint.2019.104603_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pbb.2014.03.005","article-title":"Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the leastshrew (Cryptotis parva)","volume":"120","author":"Zhong","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2019.104603_bib62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuint.2018.11.012","article-title":"Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva)","volume":"122","author":"Zhong","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2019.104603_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2018.06.035","article-title":"Intracellular emetic signaling evoked by the L-type Ca2+ channel agonist FPL64176 in the least shrew (Cryptotis parva)","volume":"834","author":"Zhong","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2019.104603_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2015.11.023","article-title":"Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew","volume":"103","author":"Zhong","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2019.104603_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104718","article-title":"Serotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+\/CaMKII-dependent ERK1\/2 signaling in the least shrew (Cryptotis parva)","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2019.104603_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autneu.2016.07.006","article-title":"Ca2+ signaling and emesis: recent progress and new perspectives","volume":"202","author":"Zhong","year":"2017","journal-title":"Auton. Neurosci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018619305686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018619305686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T06:44:47Z","timestamp":1576478687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018619305686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":66,"alternative-id":["S0197018619305686"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2019.104603","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva)","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2019.104603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104603"}}